An Ontario-based mushroom company has teamed up with Arizona State University to advance psychedelic genome research. Researchers hope to make breakthroughs in personalized medicine.
The research project seeks to advance precision medicine by identifying biomarkers and their psilocybin responses.
The recruitment process for the study asks the mushroom company, Red Light Holland, to hand out research materials to customers and gives licensed therapists the ability to refer clients.
Candace Lewis is the ASU assistant professor affiliated with the project.
“So this initiative came out of my lab and it's the idea that genomic science is definitely the path forward. Like it's the new frontier in understanding complex behaviors and complex disorders like psychiatric disorders," she said.
Red Light Holland says the study is significant amid a growing legalization of psychedelics on the global level. Possession of psilocybin remains illegal in Arizona.
-
Democratic Gov. Katie Hobbs is proposing a $17.7 billion state budget focused on affordability projects, but it relies on uncertain federal reimbursements and deals with Republicans that have yet to materialize. -
Anyone who was at Gilbert's Hale Theatre on Jan. 5, 6, 7, 8, or 9 should watch for symptoms of measles through the end of this month. -
Northern Arizona University officials say they’re halting plans for a College of Medicine amid economic uncertainty. -
Arizona has had more than 200 measles cases since June, but no cases had been confirmed in the state’s most populous county until now. -
Between August 2024 and August 2025, the number of overdose deaths in Arizona rose by almost 18%, while they fell by 20% nationally.
